途屹控股(01701.HK)2020年盈轉虧至4529.2萬元
格隆匯3月30日丨途屹控股(01701.HK)公吿,截至2020年12月31日止年度全年業績,年度收益人民幣3086.9萬元,同比減少86.8%;股東應占虧損4529.2萬元,去年則盈利2561.4萬元,盈轉虧;基本每股虧損4.53分。董事會建議不派付截至2020年12月31日止年度的末期股息。
集團一直透過加強其市場推廣方法及信息技術平台,抓住機會以奠定基礎,有關方法包括現有旅遊產品預訂系統、新的旅遊目的地商户軟件即服務("SAAS")系統、名為"店長直郵"的線上免税店業務以及相關手機應用程式,旨在讓集團搶佔及把握於行業復甦後回升的第一波旅遊需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.